Healthequity Return on Equity (ROE) Growth & History (HQY)
Healthequity's return on equity was 10.19% for fiscal 2026.
View full Healthequity company overviewHealthequity annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-01-31 | 10.19% | +5.53 pp |
| 2025 | 2025-01-31 | 4.66% | +1.83 pp |
| 2024 | 2024-01-31 | 2.83% | +4.23 pp |
| 2023 | 2023-01-31 | −1.39% | +1.35 pp |
| 2022 | 2022-01-31 | −2.74% | −3.47 pp |
| 2021 | 2021-01-31 | 0.73% | −4.53 pp |
| 2020 | 2020-01-31 | 5.26% | −12.69 pp |
| 2019 | 2019-01-31 | 17.95% | +2.38 pp |
| 2018 | 2018-01-31 | 15.57% | +4.24 pp |
| 2017 | 2017-01-31 | 11.33% | +1.77 pp |
| 2016 | 2016-01-31 | 9.56% | −5.91 pp |
| 2015 | 2015-01-31 | 15.47% | — |
Healthequity quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2027 | 2026-07-31 | 3.25% | +0.45 pp |
| Q1 2027 | 2026-04-30 | 3.34% | +0.80 pp |
| Q4 2026 | 2026-01-31 | 2.35% | +1.10 pp |
| Q3 2026 | 2025-10-31 | 2.42% | +2.15 pp |
| Q2 2026 | 2025-07-31 | 2.80% | +1.12 pp |
| Q1 2026 | 2025-04-30 | 2.54% | +1.15 pp |
| Q4 2025 | 2025-01-31 | 1.24% | −0.07 pp |
| Q3 2025 | 2024-10-31 | 0.27% | −0.48 pp |
| Q2 2025 | 2024-07-31 | 1.68% | +1.14 pp |
| Q1 2025 | 2024-04-30 | 1.39% | +1.18 pp |
| Q4 2024 | 2024-01-31 | 1.31% | +1.32 pp |
| Q3 2024 | 2023-10-31 | 0.75% | +0.83 pp |
| Q2 2024 | 2023-07-31 | 0.55% | +1.12 pp |
| Q1 2024 | 2023-04-30 | 0.21% | +0.95 pp |
| Q4 2023 | 2023-01-31 | −0.01% | +1.75 pp |
| Q3 2023 | 2022-10-31 | −0.09% | +0.18 pp |
| Q2 2023 | 2022-07-31 | −0.57% | −0.37 pp |
| Q1 2023 | 2022-04-30 | −0.74% | −0.57 pp |
| Q4 2022 | 2022-01-31 | −1.76% | −2.15 pp |
| Q3 2022 | 2021-10-31 | −0.27% | −0.40 pp |
| Q2 2022 | 2021-07-31 | −0.21% | −0.19 pp |
| Q1 2022 | 2021-04-30 | −0.16% | −0.34 pp |
| Q4 2021 | 2021-01-31 | 0.39% | +0.41 pp |
| Q3 2021 | 2020-10-31 | 0.13% | +2.23 pp |
| Q2 2021 | 2020-07-31 | −0.01% | −2.52 pp |
| Q1 2021 | 2020-04-30 | 0.18% | −8.14 pp |
| Q4 2020 | 2020-01-31 | −0.02% | −2.83 pp |
| Q3 2020 | 2019-10-31 | −2.10% | −5.62 pp |
| Q2 2020 | 2019-07-31 | 2.50% | −2.92 pp |
| Q1 2020 | 2019-04-30 | 8.31% | +2.24 pp |
| Q4 2019 | 2019-01-31 | 2.81% | +1.07 pp |
| Q3 2019 | 2018-10-31 | 3.53% | +0.30 pp |
| Q2 2019 | 2018-07-31 | 5.43% | −0.16 pp |
| Q1 2019 | 2018-04-30 | 6.08% | +1.00 pp |
| Q4 2018 | 2018-01-31 | 1.74% | +0.16 pp |
| Q3 2018 | 2017-10-31 | 3.22% | +0.78 pp |
| Q2 2018 | 2017-07-31 | 5.59% | +2.02 pp |
| Q1 2018 | 2017-04-30 | 5.08% | +1.29 pp |
| Q4 2017 | 2017-01-31 | 1.58% | +0.02 pp |
| Q3 2017 | 2016-10-31 | 2.44% | +0.34 pp |
| Q2 2017 | 2016-07-31 | 3.56% | +1.01 pp |
| Q1 2017 | 2016-04-30 | 3.79% | +0.46 pp |
| Q4 2016 | 2016-01-31 | 1.56% | +0.59 pp |
| Q3 2016 | 2015-10-31 | 2.10% | −1.93 pp |
| Q2 2016 | 2015-07-31 | 2.56% | — |
| Q1 2016 | 2015-04-30 | 3.33% | — |
| Q4 2015 | 2015-01-31 | 0.96% | — |
| Q3 2015 | 2014-10-31 | 4.03% | — |
Healthequity return on equity trends
Over the last five fiscal years, Healthequity's return on equity increased from 0.73% to 10.19%, a change of +9.46 percentage points. The latest reported quarter, Q2 2027, shows 3.25%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Healthequity source filings ↗